
Medical Science Liaison @Servier | President of Banyan Tree Clinics https://nitter.gq/t.co/YXpxhLGTDu | Heme/Onc PharmD by training | Tweets and dog photos my own
San Marcos, CA
Joined October 2019
- Tweets816
- Following638
- Followers598
- Likes1.8K
Well said
Thanks to @AJHPOfficial for allowing me to write about the deeply personal decision to leave full time clinical pharmacy & all of the complex emotions that come with it.
academic.oup.com/ajhp/advanc…
4
574
Portland area friends! Our non-profit, Banyan Tree Clinics, is having a Karaoke and Dancing Night Fundraiser! Please come out and support us supporting Cambodians!
Details and RSVP here: fb.me/e/4QvROCv4B
259
A fun talk on one of my favorite topics!
#ISOPP is proud to collaborate with Astra Zeneca Gulf and the Saudi Oncology Pharmacy Assembly (SOPA) on the 2023 Gulf Online Learning Series, Excellence in Oncology Pharmacy Practice – Chapter II. Alison Palumbo, PharmD, MPH, BCOP, presents the 2nd webinar on Lung Cancer today.
1
573
Alison Palumbo retweeted
For the PEACE-1 regimen (abiraterone + prednisone + docetaxel), the docetaxel dose is 75 mg/m2 CAPPED at 150 mg (thelancet.com/journals/lance…). Out of curiosity, does your institution dose cap?:
#oncopharm
0%Yes
0%No w/ no issues
0%No, but incr'd toxicities
100%Show me results/comment
3 votes • Final resultsFor the PEACE-1 regimen (abiraterone + prednisone + docetaxel), the docetaxel dose is 75 mg/m2 CAPPED at 150 mg (thelancet.com/journals/lance…). Out of curiosity, does your institution dose cap?:
#oncopharm
0%Yes
0%No w/ no issues
0%No, but incr'd toxicities
100%Show me results/comment
3 votes • Final resultsHappy to offer any guidance to folks wanting to apply since I have gone through the process myself :)
Now accepting #CancerResearch proposals! Grants awarded to #Pharmacist led projects that show potential to optimize patient care. Projects can focus on clinical or patient outcomes, standards benchmarking, or other worthwhile topics. #oncology #research
bit.ly/3PuIKn4
Alison Palumbo retweeted
Just out in @JAMAInternalMed, we highlight a mechanism to detect selection bias/confounding in observational studies by looking at Kaplan Meier curves.
If the curves separate implausibly early, the findings are too good to be true!
jamanetwork.com/journals/jam…
@VPrasadMDMPH
Alison Palumbo retweeted
Thanks for clarifying. There is some data with urea cream and capecitabine, but I recognize that urea may not be the global SOC.
For me, I will consider diclofenac as an alternative to, and not necessarily a replacement for urea. Would love to see a head to head study!
Alison Palumbo retweeted
According to lead presenter @batraatulmd : Urea isn’t the current global standard as the evidence is more for HFSR with VEGF TKI.
In many practices, urea is not used for prevention of capecitabine skin #Tox.
#supponc @OncoAlert
Why was diclofenac compared to placebo and not urea cream? I don’t think any of us would allow our capecitabine patients to go without urea cream for HFS prevention.
Practice changing #supponc study on how to reduce risk of hand foot syndrome from capecitabine with topical diclofenic #asco23 🧵. @OncoAlert
Check out this CME I participated in on immune checkpoint inhibitors 👇
This quoted post is unavailable.
Alison Palumbo retweeted
For a fantastic overview of the global burden of hematologic cancers check out this article in @BloodCancerJnl — it is full of detailed tables and figures to save and bookmark. #ASCO23 #MedTwitter #OpenAccess
nature.com/articles/s41408-0…
Alison Palumbo retweeted
FANTASTIC and practice changing trial from the Netherlands, SONIA shows that CDK4/6i in 2nd line are as effective as in 1st line with less Toxicity and cost.
This is what happens when you ask right questions and design studies to benefit patients instead of companies. #ASCO23 – at Chicago, IL
Walked out of the office tonight to see that someone had put this sticker on the pharmacy office door while I was working, BAHAHAHAHA! I had a good laugh :)
239
Alison Palumbo retweeted
This paper is perfect timing for #asco23. Check out the thread by Dr Olivier 👇
Our new paper is out in @jcan_policy !
w/Claire Smith, Alyson Haslam, @Alfdoc2, @VPrasadMDMPH
We explored quality of life data in the ADJUVANT settings for recent approvals.
👉approach QoL results of ADJUVANT trials with great caution❗️#ASCO2023
Here is why, short 🧵👇
1/5
Alison Palumbo retweeted
Take 🏠 points:
🔷 53% of oncologists/trainees experience imposter syndrome on social media (women>men)
🔶 Social media remains a more positive than negative experience
🔷 One factor driving IS is feeling insecure to comment/ engage due to comparison w disease experts.
#ASCO23




























